| Application no. and date | 06849865.8 (espacenet) (Federated) (European Patent Register), 20061031 | | Patent/reg. no. and date | DK/EP 1948235, 20130828 | | Publication date | 20080730 | | Priority no. and date | US 732444 P, 20051101 | | EP pub. no. and date |
EP 1948235 20080730 | | Effective date | | | Applicant/owner | AbbVie Biotechnology Ltd, Harbour Fiduciary Services Limited
Thistle House
4 Burnaby Street
Hamilton Pembroke HM 11 , BM | | Applicant ref. no. | P012940EPDK1 EJ/GB/Ve | | Inventor | MAKSYMOWYCH, Walter, P., Department Of Medicine & Radiology
University Of Alberta
562 Heritage Medical Research Center
Edmonton, Alberta, T6G 252, CA,
WONG, Robert, L., 12 Riggs Court
Basking Ridge, NJ 07920, US | | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK | | Opponent | | | IPC Class | G01N 33/68 (2006.01) | | Title | Fremgangsmåder til bestemmelse af effektiviteten af adalimumab hos patienter med Bechterews sygdom med CTX-II og MMP3 som biomarkører | | Int. application no. | US2006042564 | | Int. publication no. | WO2007089303 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
